// App-Quantinova.ai

PO1990 : TRPC6 Is a Key Mediator of a PAR-1 Activation Pathway in Podocytes That Is Responsible for FSGS

Researchers

Presenter

  • May CarlJ

Principal Investigators

  • Chesor Musleeha

  • Welsh GavinIain

  • Saleem Moin

Medical Centers

  • University of Bristol, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Nephrotic syndrome

  • Nephrotic syndrome 2

  • Focal segmental glomerulosclerosis

Biomarkers

  • Alpha-Actinin 4

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A